Fetal hydrops caused by a novel pathogenic MECOM variant

Prenat Diagn. 2023 Jun;43(6):717-720. doi: 10.1002/pd.6353. Epub 2023 May 17.

Abstract

We report a fetus with hydrops, congenital heart disease and bilateral radioulnar synostosis caused by a novel pathogenic MECOM variant. The female fetus was referred for post-mortem examination after fetal hydrops and intrauterine death was diagnosed at 20 weeks gestation. Post-mortem examination confirmed fetal hydrops, pallor, truncus arteriosus and bilateral radioulnar synostosis. Trio whole genome sequencing analysis detected a novel de novo heterozygous pathogenic loss-of-function variant in MECOM (NM_004991), associated with a diagnosis of Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia 2 (RUSAT-2). RUSAT-2 is a variable condition associated postnatally with bone marrow failure, radioulnar synostosis and congenital anomalies. RUSAT-2 is not currently associated with a prenatal phenotype or fetal demise, and was not present on diagnostic NHS prenatal gene panels at time of diagnosis. This case highlights the diagnostic value of detailed phenotyping with post-mortem examination, and of using a broad sequencing approach.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Humans
  • Hydrops Fetalis* / diagnosis
  • Hydrops Fetalis* / genetics
  • MDS1 and EVI1 Complex Locus Protein
  • Pregnancy
  • Prenatal Diagnosis
  • Radius / abnormalities
  • Synostosis* / complications
  • Synostosis* / genetics
  • Ulna / abnormalities

Substances

  • MDS1 and EVI1 Complex Locus Protein
  • MECOM protein, human

Supplementary concepts

  • Radioulnar Synostosis